Development
C
Johnson & Johnson JNJ
$155.03 $1.370.89% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 10/01/2023 07/02/2023 04/02/2023 01/01/2023
Net Income -- -- 7,664.71% -101.93% -21.04%
Total Depreciation and Amortization -- -- 2.87% 66.22% -32.88%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -- -- 39.49% -142.21% 1,033.33%
Change in Net Operating Assets -- -- -206.10% 282.65% -4,030.00%
Cash from Operations -- -- 28.40% -39.12% -14.86%
Capital Expenditure -- -- -30.24% 45.62% -66.70%
Sale of Property, Plant, and Equipment -- -- 90.00% -81.90% 2,662.50%
Cash Acquisitions -- -- -- -- -1,713,100.00%
Divestitures -- -- -- -- --
Other Investing Activities -- -- -165.93% -70.65% 1,960.03%
Cash from Investing -- -- -213.91% 175.39% -158.50%
Total Debt Issued -- -- -94.00% 107.70% 231.35%
Total Debt Repaid -- -- -39.67% -237.81% 33.17%
Issuance of Common Stock -- -- -- -- 385.06%
Repurchase of Common Stock -- -- 89.57% -168.79% 39.03%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -5.10% 0.41% 0.54%
Other Financing Activities -- -- 1,811.90% 85.53% -273.41%
Cash from Financing -- -- -197.61% 261.06% 143.31%
Foreign Exchange rate Adjustments -- -- -446.43% -76.47% 141.61%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -- -- -144.61% 359.52% 645.16%